- PZU’s third-quarter net income reached 2.00 billion zloty, marking a 64% increase compared to the previous year.
- This net income figure surpassed the estimated 1.63 billion zloty.
- Insurance sales rose to 7.90 billion zloty, a 4.8% increase year-over-year, slightly exceeding the forecast of 7.77 billion zloty.
- Operating profit for the third quarter was 5.12 billion zloty, up 26% from the same period last year, and above the projected 4.3 billion zloty.
- For the nine-month period, PZU reported a net income of 5.23 billion zloty, which is a 43% increase year-over-year.
- Analyst recommendations include 5 buy ratings, 6 hold ratings, and 1 sell rating for PZU.
A look at Powszechny Zaklad Ubezpieczen Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Powszechny Zaklad Ubezpieczen shows a promising long-term outlook. With a high dividend score of 5, investors may find the company attractive for potential income generation. Additionally, a solid value score of 4 suggests that the company’s stock may be undervalued, presenting a good opportunity for long-term investments. The growth score of 4 indicates that Powszechny Zaklad Ubezpieczen has the potential for expansion and increasing market share.
However, the company’s resilience and momentum scores are lower at 3, indicating some room for improvement in these areas. Despite this, Powszechny Zaklad Ubezpieczen‘s diversified offerings including property, casualty, and life insurance products position it well in the insurance sector for long-term stability and growth.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
